| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 82/03/24 | 101/01/12 | 陳正 | 朱佳真 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.12(Q2) | 138.95 | 1.95 | 0.66% |
| 實收資本額 | 已發行普通股 | ||
| 1,093,758,510 | 109,375,851 | ||
| 主要經營業務 | |||
| 研究,開發,生產,製造及銷售各種西藥製劑各種西藥品,西藥原料之銷售及進出口業務各種藥物之臨床試驗服務 | |||
| 公司網址 | |||
| genovate-bio.com | |||
健亞(4130) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 47,136 | 38,846 | 4.3% | 21.3% | 364,329 | 286,319 | 27.2% |
| 2023/07 | 45,187 | 39,350 | -4.1% | 14.8% | 317,193 | 247,473 | 28.2% |
| 2023/06 | 47,122 | 38,287 | -6.9% | 23.1% | 272,006 | 208,123 | 30.7% |
| 2023/05 | 50,634 | 35,936 | 18.6% | 40.9% | 224,884 | 169,836 | 32.4% |
| 2023/04 | 42,675 | 34,234 | -18.3% | 24.6% | 174,250 | 133,900 | 30.1% |
| 2023/03 | 52,221 | 35,175 | 45.7% | 48.5% | 131,575 | 99,666 | 32% |
| 2023/02 | 35,846 | 26,589 | -17.6% | 34.8% | 79,354 | 64,491 | 23% |
| 2023/01 | 43,508 | 37,902 | 53.7% | 14.8% | 43,508 | 37,902 | 14.8% |
| 2022/12 | 28,303 | 40,565 | -34.5% | -30.2% | 438,759 | 434,254 | 1% |
| 2022/11 | 43,194 | 37,730 | -1.4% | 14.5% | 410,456 | 393,689 | 4.3% |
| 2022/10 | 43,790 | 33,946 | 17.9% | 29% | 367,262 | 355,959 | 3.2% |
| 2022/09 | 37,153 | 39,498 | -4.3% | -5.9% | 323,472 | 322,013 | 0.4% |
| 2022/08 | 38,846 | 41,129 | -1.3% | -5.6% | 286,319 | 282,515 | 1.3% |
| 2022/07 | 39,350 | 37,553 | 2.8% | 4.8% | 247,473 | 241,386 | 2.5% |
| 2022/06 | 38,287 | 32,335 | 6.5% | 18.4% | 208,123 | 203,833 | 2.1% |
| 2022/05 | 35,936 | 36,920 | 5% | -2.7% | 169,836 | 171,498 | -1% |
| 2022/04 | 34,234 | 31,028 | -2.7% | 10.3% | 133,900 | 134,578 | -0.5% |
| 2022/03 | 35,175 | 34,934 | 32.3% | 0.7% | 99,666 | 103,550 | -3.8% |
| 2022/02 | 26,589 | 22,851 | -29.8% | 16.4% | 64,491 | 68,616 | -6% |
| 2022/01 | 37,902 | 45,765 | -6.6% | -17.2% | 37,902 | 45,765 | -17.2% |
| 2021/12 | 40,565 | 24,511 | 7.5% | 65.5% | 434,254 | 472,723 | -8.1% |
| 2021/11 | 37,730 | 24,831 | 11.1% | 51.9% | 393,689 | 448,212 | -12.2% |
| 2021/10 | 33,946 | 42,114 | -14.1% | -19.4% | 355,959 | 423,381 | -15.9% |
| 2021/09 | 39,498 | 41,351 | -4% | -4.5% | 322,013 | 381,267 | -15.5% |
| 2021/08 | 41,129 | 35,338 | 9.5% | 16.4% | 282,515 | 339,916 | -16.9% |
| 2021/07 | 37,553 | 44,710 | 16.1% | -16% | 241,386 | 304,578 | -20.7% |
| 2021/06 | 32,335 | 46,378 | -12.4% | -30.3% | 203,833 | 259,868 | -21.6% |
| 2021/05 | 36,920 | 38,988 | 19% | -5.3% | 171,498 | 213,490 | -19.7% |
| 2021/04 | 31,028 | 38,667 | -11.2% | -19.8% | 134,578 | 174,502 | -22.9% |
| 2021/03 | 34,934 | 46,974 | 52.9% | -25.6% | 103,550 | 135,835 | -23.8% |
| 2021/02 | 22,851 | 41,029 | -50.1% | -44.3% | 68,616 | 88,861 | -22.8% |
| 2021/01 | 45,765 | 47,832 | 86.7% | -4.3% | 45,765 | 47,832 | -4.3% |
| 2020/12 | 24,511 | 32,278 | -1.3% | -24.1% | 472,723 | 465,756 | 1.5% |
| 2020/11 | 24,831 | 39,383 | -41% | -36.9% | 448,212 | 433,478 | 3.4% |
| 2020/10 | 42,114 | 34,335 | 1.8% | 22.6% | 423,381 | 394,095 | 7.4% |
| 2020/09 | 41,351 | 39,213 | 17% | 5.4% | 381,267 | 359,760 | 6% |
陞泰(8072) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 7.26% | -4.49% | 2020Q3 | 89.45% | 21.24% |
| 2023Q1 | -1.57% | -5.07% | 2020Q2 | 17.59% | 5.34% |
| 2022Q4 | -17.27% | -4.40% | 2020Q1 | -14.04% | 0.58% |
| 2022Q3 | -3.72% | -2.50% | 2019Q4 | -7.12% | 2.91% |
| 2022Q2 | 2.76% | -1.55% | 2019Q3 | 32.78% | 2.60% |
| 2022Q1 | 0.53% | -0.01% | 2019Q2 | -3.25% | -6.19% |
| 2021Q4 | -8.93% | -5.75% | 2019Q1 | -6.32% | -6.82% |
| 2021Q3 | -0.02% | -3.86% | 2018Q4 | -9.18% | -3.96% |
| 2021Q2 | 9.20% | 10.07% | 2018Q3 | -5.61% | -5.99% |
| 2021Q1 | -19.95% | 11.44% | 2018Q2 | -6.28% | -3.79% |
| 2020Q4 | -1.59% | 18.48% | 2018Q1 | 4.95% | -3.82% |
評論0